期刊文献+

氯化锂阻滞DNA合成抑制前列腺癌生长 被引量:1

LiCI suppresses tumor growth and inhibits DNA replication in prostate cancer
原文传递
导出
摘要 目的研究氯化锂对前列腺癌生长的影响并探讨其作用机制。方法选用人前列腺癌PC.3细胞株,采用体外培养和裸鼠背部皮下移植观察氯化锂对细胞生长的影响,应用四甲基偶氮唑盐(MTT)法、细胞BrdU掺入实验和Westernblot方法探讨细胞增殖活性和DNA复制相关蛋白的变化。结果细胞培养第3天,经10mmol/L氯化锂处理的前列腺癌PC一3细胞数为1.9×10^5,与PBS对照组的4.8×10^5比较差异有统计学意义(P〈0.05)。氯化锂及对照组氯化钠、氯化钾处理组的细胞增殖抑制率分别为50%、95%及98%,差异有统计学意义(P〈0.05)。在氯化锂浓度为10、30mmol/L时,BrdU掺入吸光度(A)值分别为1.5、1.3,与PBS对照组为4相比差异有统计学意义(P〈0.05)。在氯化锂作用下DNA复制相关蛋白cdc6、cdc25C、cyclinA和cyclinE蛋白水平下调、CDK抑制剂p21。“蛋白水平上调。动物实验结果示腹腔注射氯化锂组移植瘤的平均体积为50mm。,平均体质量为296mg,均明显小于PBS对照组的180mm^3和957mg,差异有统计学意义(P〈0.05)。结论体内外实验氯化锂均可抑制前列腺癌PC-3细胞株生长,其机制可能与阻滞细胞DNA合成有关。 Objective To assess the effects of LiCl on prostate cancer growth and to explore the underlying mechanisms. Methods Effects of LiCl on cell growth in vitro and in vivo were determined by cell counting and xenografts of prostate cancer cells. Alterations in cell proliferation and the expression of DNA replication-related protein were determined by MTT assay, BrdU incorporation and Western blot. Results Compared to PBS control group, the number of prostate cancer cells ( PC-3 ) were lower treated with 10 mmol/L LiCl,the number was 1.9 x 10^5 , 4. 8 ×10^5 and the difference was significant (P 〈0. 05). The inhibition rate of cellular proliferation were 50% ,95% and 98%, respectively, in LiCl group, NaC1 and KC1 control group, the difference was significant( P 〈0.05 ). The A-Value of BrdU incorporation was 1.5,1.3 treated with 10 mmol/L, 30 mmol/L LiCl, while the A-value of BrdU incorporation was 4 in PBS control group, the difference was significant ( P 〈 0. 05 ). On the protein level, LiCl downregulates expression of cdc 6, cyclins A and cyclins E, and cdc 25C, and upregulates expression of the CDK inhibitor p21 CIP1. The mean volume and weight of xenograft tumor were 50 mm^3 and 296 mg after LiCl intraperitoneal injection, But PBS control group were 180 mm3 and 957 mg, the difference was significant(P 〈 0. 05). Conclusion LiCl disrupts DNA replication and suppresses tumor growth of prostate cancer cells in vitro and in vivo.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2012年第7期475-478,共4页 Chinese Journal of Pathology
基金 浙江省医学重点学科建设计划项目(GJSX-010-004) 浙江省公益性技术应用研究计划项目(实验动物)(2011C37081)
关键词 前列腺肿瘤 细胞周期 核酸合成抑制剂 Prostatic neoplasms Cell cycle Nucleic acid synthesis inhibitors
  • 相关文献

参考文献14

  • 1Huot J, Nosal G, Radoucu-Thomas S. Effects of lithium chloride on normal and neoplastic cells in vitro. Experientia, 1972,28 (4) : 456-457.
  • 2Ballin A, Aladjem M, Banyash M, et al. The effect of lithium chloride on tumour appearance and survival of melanoma-bearing mice. BrJ Cancer, 1983, 48(1) : 83-87.
  • 3Cohen Y, Chetrit A, Cohen Y, et al. Cancer morbidity in psychiatric patients : influence of lithium carbonate treatment. Med Oncol, 1998,15 ( 1 ) :32-36.
  • 4Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A, 1996,93 (16) : 8455-8459.
  • 5Erdal E, Ozturk N, Cagatay T, et al. Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells. Int J Cancer, 2005, 115 ( 6 ) : 903-910.
  • 6Liao X, Thrasher JB, Holzbeierlein J, et al. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer. Endocrinology, 2004, 145 ( 6 ) : 294 1-2949.
  • 7Liao X, Zhang L, Thrasher JB, et al. Glycogen synthase kiuase- 3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer. Mol Cancer Ther, 2003, 2( 11 ) : 1215-1222.
  • 8Miyake H, Nelson C, Rennie PS, et 81. Overexpression of insutin- like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway. Endocrinology ,2000,141 (6) :2257 -2255.
  • 9w_ Paul R, Breul J. Antiandrogen withdrawal syndrome associated with prostate cancer therapies : incidence and clinical significance. Drug Saf, 2000, 23(5) : 381-390.
  • 10Manoukian AS, Woodgett JR. Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. Adv Cancer Res,2002, 84:203-229.

同被引文献2

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部